Equities

Alterola Biotech Inc

ABTI:PKC

Alterola Biotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.009
  • Today's Change0.00 / 0.00%
  • Shares traded11.90k
  • 1 Year change+50.00%
  • Beta0.7580
Data delayed at least 15 minutes, as of Oct 08 2024 17:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alterola Biotech, Inc. is a pharmaceutical company. The Company is engaged in the development of cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs); pharmaceutical medicines made from cannabinoid, cannabinoid-like, and non-cannabinoid APIs; and European food approval of cannabinoid-based, cannabinoid-like, and non-cannabinoid ingredients and products. The Company has three areas of focus: development of regulated pharmaceuticals (human and animal health) and regulated food products; production of APIs and food-grade ingredients; and formulation, and drug delivery, providing bioavailability, solubility, and stability. It also focuses on developing new medicines from various sources, including botanical, traditional chemical synthesis, and biosynthetic methodologies. Its wholly owned subsidiaries include ABTI Pharma Ltd, Phytotherapeutix Ltd, and Ferven Ltd.

  • Revenue in USD (TTM)0.00
  • Net income in USD-2.06m
  • Incorporated2008
  • Employees1.00
  • Location
    Alterola Biotech Inc47 Hamilton SquarBIRKENHEAD CH415ARUnited KingdomGBR
  • Phone+1 909 584 5853
  • Websitehttps://alterola-abti.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jaguar Health Inc10.19m-35.67m11.92m49.00--0.5973--1.17-41.34-41.346.622.480.17930.2317.56207,857.10-63.73-95.29-110.34-163.5479.7967.28-355.51-522.281.60-3.450.6333---18.3617.1912.97------
NKGen Biotech Inc0.00-88.25m12.08m63.00---------3.74-3.740.00-2.710.00----0.00-480.25-----------------0.4822-----100.00---210.06------
Vincerx Pharma Inc0.00-28.90m12.09m42.00--0.7827-----1.31-1.310.000.52060.00----0.00-101.76---136.61--------------0.00------36.24------
Nymox Pharmaceutical Corp0.00-8.84m12.16m3.00---------0.0966-0.09660.00-0.03390.00-------785.44-306.39---749.37-------43,683.47---157.57---------34.49---39.16--
Eom Pharmaceutical Holdings Inc0.00-4.93m12.40m3.00---------0.0435-0.04350.00-0.0212------0.00---126.34---171.37------------7.41-------254.37------
Cell Source Inc0.00-6.45m12.58m-----------0.1627-0.16270.00-0.4130.00-------1,300.91-1,758.85---------------5.14---------3.55------
Kazia Therapeutics Ltd (ADR)15.22k-13.80m12.69m12.00--1.20--834.08-0.8373-0.83730.00080.35650.0007--73.97---63.98-46.35-82.39-54.75-----90,714.45-497.17----0.1297--979.43-28.3118.19------
Aspira Women's Health Inc8.92m-15.95m13.04m64.00------1.46-1.45-1.450.801-0.28921.5315.115.79139,421.90-273.16-110.58-3,758.30-151.8857.8445.23-178.80-334.080.5542-17,354.00----11.8524.5644.15---26.65--
Alterola Biotech Inc0.00-2.06m13.14m1.00---------0.0017-0.00170.00-0.0010.00----0.00-32.46---46.53----------0.0073-----------14.64------
Cadrenal Therapeutics Inc0.00-6.24m13.21m4.00--3.31-----5.88-5.880.003.740.00----0.00-138.35---173.80--------------0.00-------24.47------
Pharmacyte Biotech Inc0.004.50m13.52m2.003.480.28473.01--0.50580.50580.006.870.00----0.0035.90-7.4238.19-7.68------------0.00-------299.38------
Cingulate Inc0.00-19.10m13.70m13.00--1.14-----141.60-141.600.003.950.00----0.00-368.85-----------------47.380.0042-------33.14------
Edesa Biotech Inc0.00-6.93m13.96m16.00--4.87-----2.21-2.210.000.88290.00----0.00-94.60---128.81--------------0.00------52.28------
Aprea Therapeutics Inc1.28m-12.93m14.13m7.00--0.5526--11.08-3.03-3.030.28984.950.0435----182,241.40-44.09-68.66-50.11-77.19-----1,013.41-42,112.84----0.00------87.32--90.61--
Lyra Therapeutics Inc1.82m-101.39m14.31m87.00--0.4619--7.86-1.61-1.610.02940.47330.0165----20,681.82-92.07-58.01-108.51-68.69-----5,570.88-6,235.31----0.00--14.314.60-13.39--95.14--
Data as of Oct 08 2024. Currency figures normalised to Alterola Biotech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.